Insights

Strategic Focus Nascent Biotech specializes in immunotherapy and monoclonal antibodies targeting brain and pancreatic cancers, signaling collaboration opportunities with oncology-focused CROs, contract manufacturing, and translational research partners seeking novel mAb platforms.

Clinical Partnerships Recent collaborations and advisory board additions, including clinical trial activity with Sharp HealthCare and the involvement of scientific advisors, present openings for sponsorships, joint development agreements, and consulting engagements to advance PTB programs.

Regulatory Readiness Public company with ongoing development of a proprietary antigen targeting cancer cells; potential sales opportunities include regulatory consulting, IND/CMC support, and strategic funding discussions with niche investment firms and biotech funds.

External Validation Historical partnerships and funding from Triton Funds and BioTools indicate market interest in PTB; leverage these signals to approach potential co-development, licensing, or research collaboration opportunities with oncology-focused investors and service providers.

Market Education The strong mAb market tailwinds and rising adoption of immunotherapies create a chance to offer clinical research services, data analytics, and commercialization planning support to help position PTB within brain cancer and pancreatic cancer treatment landscapes.

Similar companies to Nascent Biotech, Inc.

Nascent Biotech, Inc. Tech Stack

Nascent Biotech, Inc. uses 8 technology products and services including iCIMS, WordPress, Shopify, and more. Explore Nascent Biotech, Inc.'s tech stack below.

Media & News

Nascent Biotech, Inc.'s Email Address Formats

Nascent Biotech, Inc. uses at least 1 email format:
Nascent Biotech, Inc. Email FormatsExamplePercentage
First.Last@nascentbiotech.comJohn.Doe@nascentbiotech.com
100%

Frequently Asked Questions

What is Nascent Biotech, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Nascent Biotech, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nascent Biotech, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Nascent Biotech, Inc.'s official website is nascentbiotech.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nascent Biotech, Inc. generate?

Minus sign iconPlus sign icon
As of September 2026, Nascent Biotech, Inc.'s annual revenue is estimated to be <$1M.

What is Nascent Biotech, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Nascent Biotech, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Nascent Biotech, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2026, Nascent Biotech, Inc. has approximately 1 employees across 1 continents, including North America. Key team members include Chief Executive Officer: S. C. and Medical Advisory Board: V. Z. Explore Nascent Biotech, Inc.'s employee directory with LeadIQ.

What industry does Nascent Biotech, Inc. belong to?

Minus sign iconPlus sign icon
Nascent Biotech, Inc. operates in the Biotechnology Research industry.

What technology does Nascent Biotech, Inc. use?

Minus sign iconPlus sign icon
Nascent Biotech, Inc.'s tech stack includes iCIMS, WordPress, Shopify, Microsoft 365, Backbone.js, Lightbox, Modernizr and Piwik PRO Core.

What is Nascent Biotech, Inc.'s email format?

Minus sign iconPlus sign icon
Nascent Biotech, Inc.'s email format typically follows the pattern of First.Last@nascentbiotech.com. Find more Nascent Biotech, Inc. email formats with LeadIQ.

How much funding has Nascent Biotech, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2026, Nascent Biotech, Inc. has raised $3.9M in funding. The last funding round occurred on Feb 23, 2022 for $750K.

When was Nascent Biotech, Inc. founded?

Minus sign iconPlus sign icon
Nascent Biotech, Inc. was founded in 2014.
Nascent Biotech, Inc. logo

Nascent Biotech, Inc.

Biotechnology ResearchCalifornia, United States0-1 Employees

Nascent Biotech, Inc. is a biotechnology research company based in San Diego, California, founded in 2014. Its principal focus is the development of monoclonal antibody therapies, notably Pritumumab, which targets a proprietary antigen on cancer cells with the goal of treating brain and pancreatic cancers. The company operates within the immunotherapy segment of oncology, emphasizing strategies that modulate the body's immune response to combat disease. Nascent Biotech collaborates with scientific advisors and external partners to advance its research and clinical initiatives, including activities that support characterization of molecular structure and collaboration with healthcare organizations for potential clinical trials. Recent developments include additions to its scientific advisory team and partnerships intended to define the higher order molecular structure of its antibody candidate.“ } } {

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
0-1

Section iconFunding & Financials

  • $3.9M

    Nascent Biotech, Inc. has raised a total of $3.9M of funding over 5 rounds. Their latest funding round was raised on Feb 23, 2022 in the amount of $750K as a Grant.

  • <$1M

    Nascent Biotech, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.